Please login to the form below

Monsanto

This page shows the latest Monsanto news and features for those working in and with pharma, biotech and healthcare.

Bayer axes 1,250 pharma jobs, with R&D taking the brunt

The shake-up – which follows its $66bn takeover of agricultural products company Monsanto – will also result in the sale of its animal health division to narrow its focus to pharma, consumer ... and agility.” He also insisted that the moves have

Latest news

Pharma sales help Bayer escape the worst from a bumpy 2017

group Monsanto - which it now expects to complete before June - won’t derail its other business units.
Joerg Moeller to head Bayer R&D after operational shake-up

Moeller is taking over the R&D helm at a pivotal point for Bayer, which has been in the throes of a mega-merger with Monsanto - finalised today - while also working
EMA clears Bayer's Stivarga for liver cancer

PAH) therapy Adempas (riociguat) - that Bayer needs to drive its pharma unit as it digests Monsanto - bought for $66bn last September.
Bayer: Post-truth politics severely handicaps innovation

US of Bayer’s $66bn acquisition of agri-business firm Monsanto.
Xarelto and Eylea continue to dominate Bayer's pharma sales

Monsanto acquisition 'won't curtail pharma deals'. Overall, group sales rise 1.5% to 46.8bn in 2016, in a year that saw Bayer agree in September a $66bn deal to ... and that the company's long-term funding plans would not be impacted by the Monsanto deal.

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Latest Intelligence

Innovation in merger control and the impact on the pharmaceutical sector

This was its position in the recent Dow/ DuPont and Bayer/Monsanto mergers, where the Commission found that each transaction would have ‘significantly reduced competition in a number of markets’ and
Taking a lean and careful approach

He has also served as a group leader at Monsanto Co, a senior staff fellow at the National Institutes of Health and as an assistant professor at the University of Maryland.
Deal Watch May 2016

In the same vein, focusing its interests, Bayer put in a $62bn opening bid [$122 per share] to purchase Monsanto, which bid has been rejected as insufficient.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Alexion Pharmaceuticals adds to its board

Reinsdorf, who has a background in corporate governance and expertise in managing corporate and legal affairs, has served in various positions for companies including Tyco International and Monsanto.
Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences

Shailubhai has also previously served at Callisto Pharmaceuticals, Monsanto Company and as a senior staff fellow at the National Institutes of Health (NIH).
H&T Asia promotes Monika James

Monsanto, MSD and Danone.
JDRF names new CEO

The choice is a change of direction for Rapp, who was most recently mergers and acquisitions lead for the chemical firm Monsanto Company and has served as CEO of the
Peacock steps down as Amgen CFO

His prior experience includes roles at Tanox, Biogen and Monsanto Life Sciences.

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

AM / Senior Account Manager – Healthcare PR - London / Remote: Highly Competitive Salary, Bonus &Benefits

Entry Level Account Executive – Healthcare Advertising – London...: Salary TBC

Medical Writers > Scientific Directors – Medical Communicatio...: Highly Competitive Salary, Bonus &Benefits

Scientific Director, MRNA/ Covid 19, Medical Communications, UK: Six figure salary

FREELANCE Associate Director - Healthcare PR - Remote or London: Superb Day Rate &Benefits

Client Services Director, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

B2B media account director: Competitive salary

HR Manager – Recruitment/ Generalist combined role, Marketing ag...: circa £50K

Senior Account Exec > CSD – Medical Communications – UK, Lond...: Highly Competitive Salary, Bonus &Benefits

Principal Medical Writer, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Vaccines writer – career opportunity to move into medcomms from ...: Highly competitive salary

PMHub

Add my company

Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs: In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?: Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:: Securing a future for telehealth with immersive market research insights...

Email:
Password:

Please login to the form below

Monsanto

COVID-19 Updates and Daily News

Featured jobs

Quick links